The global healthcare industry, a cornerstone of human well-being and longevity, is simultaneously a significant contributor to the planet’s environmental…
Read More
Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced a significant expansion…
Read More
Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential
Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The global biotechnology sector is experiencing a significant resurgence, marked by robust investment, strategic mergers and acquisitions, and groundbreaking scientific…
Read More
Eli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 Trials
INDIANAPOLIS, IN – Eli Lilly and Company has announced groundbreaking Phase 3 trial results for its investigational drug, retatrutide, a…
Read More
What if psilocybin works about as well for depression as an SSRI?
The fervent hope surrounding classic psychedelics as a revolutionary treatment for depression may be tempering, with recent data suggesting that…
Read More
Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratoses (AK) initiates a challenging journey to prevent the progression to skin cancer.…
Read More
CEPI Fast-Tracks Ebola Vaccine Candidates from IAVI, Moderna, and Oxford
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced a critical initiative to accelerate the development of three investigational vaccines…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…
Read MoreYOU MAY HAVE MISSED
